|Year : 2019 | Volume
| Issue : 2 | Page : 198-202
Characterization of oral fibroblasts: An in vitro model for oral fibrosis
Pooja Adtani1, Malathi Narasimhan2, Kannan Ranganathan3, Alan Punnoose4, Prathibha Prasad1, Prabhu Manickam Natarajan5
1 Department of Oral Pathology, College of Dentistry, Gulf Medical University, Ajman, United Arab Emirates
2 Department of Oral Pathology and Microbiology, Faculty of Dental Sciences, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India
3 Department of Oral and Maxillofacial Pathology, Ragas Dental College, Chennai, Tamil Nadu, India
4 Research Center for Regenerative Medicine and Stem Cell Research, Central Research Facility, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India
5 Department of Periodontics, College of Dentistry, Gulf Medical University, Ajman, United Arab Emirates
|Date of Submission||03-Apr-2019|
|Date of Acceptance||08-May-2019|
|Date of Web Publication||20-Aug-2019|
Department of Basic Dental Sciences (Oral Pathology), College of Dentistry, Gulf Medical University, Ajman
United Arab Emirates
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Oral submucous fibrosis (OSMF) is a chronic debilitating condition of the oral mucosa that has been classified as a potentially malignant disorder with a malignant transformation rate of 2%–8%. Several in vitro and in vivo experiments have been performed to formulate a treatment modality for OSMF, yet no ideal in vitro primary oral fibroblast model has been developed.
Aim: To establish an in vitro primary oral fibroblast model.
Setting and Design: In vitro laboratory setting.
Materials and Methodology: Primary cell culture protocol was performed after obtaining normal oral tissue. Karyotyping was performed to rule out chromosomal abnormalities. Immunofluorescence staining was carried with a panel of fibroblast-specific markers (vimentin, phalloidin, transforming growth factor-β receptor 1 [TGFβR1] and s100a4) and Masson trichrome staining (MTS) to demonstrate the presence of extracellular matrix (ECM) qualitatively.
Results: A monolayer of oral fibroblasts was observed on the 9th-day postseeding. No chromosomal abnormality was observed in the patient samples. Positive staining was observed with vimentin, phalloidin, TGFβR1 and s100a4, thereby confirming the cell type. MTS revealed fibroblasts with spindle morphology and scanty ECM.
Conclusion: The present study lays down a protocol to design and characterize primary buccal fibroblast cell culture model that would aid researchers in performing in vitro preliminary experiments in areas concerning fibrosis.
Keywords: Fibrosis, oral fibroblasts, phalloidin, transforming growth factor
|How to cite this article:|
Adtani P, Narasimhan M, Ranganathan K, Punnoose A, Prasad P, Natarajan PM. Characterization of oral fibroblasts: An in vitro model for oral fibrosis. J Oral Maxillofac Pathol 2019;23:198-202
|How to cite this URL:|
Adtani P, Narasimhan M, Ranganathan K, Punnoose A, Prasad P, Natarajan PM. Characterization of oral fibroblasts: An in vitro model for oral fibrosis. J Oral Maxillofac Pathol [serial online] 2019 [cited 2019 Sep 22];23:198-202. Available from: http://www.jomfp.in/text.asp?2019/23/2/198/264823
| Introduction|| |
Oral submucous fibrosis (OSMF) is defined as a chronic, progressive, scarring disease that predominantly affects people of Southeast Asian origin. The initial stages of OSMF commence with fibrotic bands at the retromolar region that further progresses to the buccal mucosa gradually involving the soft palate, uvula, faucial pillars and sometimes the pharynx., Induction of fibrosis in buccal cells during areca nut chewing and arecoline association (17.6%) was clearly demonstrated in the Taiwanese population. In an in vitro study, on performing real-time polymerase chain reaction, upregulation of transforming growth factor β1 (TGFβ1) and downregulation of bone morphogenetic protein 7 were observed, signifying increased collagen deposition. Processed fibroblast cell lines (gingival, dermal, uterine, bladder, foreskin and 3T3 [Swiss albino mouse embryo]) (ATCC cell lines) are available for carrying out in vitro experiments, but they are not suitable for studying mechanisms involved in OSMF.In vitro studies on human buccal cell line-based model would be alongside the in vivo response of arecoline-induced fibrosis that would help in identifying morphological changes during the early stages of fibrogenesis. Hence, we attempted to isolate and seed primary cell cultures from human buccal cells.
Primary fibroblast cultures were assessed for morphology using microscopy (shape and numbers) and for chromosomal abnormalities by performing karyotyping, to determine the cell type and origin, to demonstrate in vitro fibroblast differentiation using immunohistochemistry and finally to demonstrate collagen production in the extracellular matrix (ECM); Masson trichrome staining (MTS) was also performed.
| Materials and Methodology|| |
The study was carried out after obtaining institutional ethical committee approval (IEC-NI/II/APR/22/19). The present study was an in-vitro study; therefore, an average of three samples was obtained from three patients. Patients were duly informed about the study design. After obtaining approval, approximately 4 mm of tissue was collected from normal buccal mucosa. Tissue samples were collected from patients who underwent third molar impaction surgery at the Department of Oral and Maxillofacial Surgery, Faculty of Dental Sciences, Sri Ramachandra Medical College and Research Institute, Chennai.
The inclusion criteria involved healthy subjects aged above 21 years undergoing third molar impaction surgery, with no habits (tobacco chewing, smoking and alcohol consumption) and with normal mucosa.
The exclusion criteria were subjects with habits such as tobacco chewing, smoking and alcohol consumption; those taking drugs that could affect fibroblastic activity, e.g., calcium channel blockers, phenytoin sodium, cyclosporine and steroids; patients having diabetes mellitus, hypertension and ischemic heart disease and finally children below 12 years.
Standardization procedure for attaining primary fibroblast cell culture from buccal tissue samples was performed according to a protocol published earlier by Adtani et al. in 2017. Dulbecco's modified eagle's medium (DMEM) optimized the multiplication and expansion of the fibroblast population. Of the three samples, the yield of viable cells ranged from 105 to 106/mL requiring seeding with adjusted appropriate volumes of harvested cells at the rate of 103/mL. The morphology of established cultures is shown in [Figure 1]a, [Figure 1]b, [Figure 1]c.
|Figure 1: Establishment and morphology of primary cell cultures of human oral buccal fibroblasts showing (a) seeded cells, (b) 3 days postinoculation and (c) confluency on the 9th day. Images taken using confocal microscopy|
Click here to view
Cultured human buccal fibroblasts (HBFs) for the first in mitotic phase were harvested into T25 flasks for karyotyping. Seventy-five microliters of colcemid was added to arrest cells in metaphase and to separate the chromosomes for cytogenetic studies. Four milliliters of trypsin-ethylenediaminetetraacetate was added for detachment of cells. The detached cells were subjected to centrifugation at 1000 rpm for 10 min. To the pellet of cells formed, 1 mL of prewarmed hypotonic solution (potassium chloride) was added and subjected to centrifugation. The second pellet of cells thus formed was fixed with prechilled fixative (Carnoy's fixative). A few drops of cells were cast on a prechilled, clean glass slide from a height of 10–12 cm with the slide at an angle of 45°. The slides were then dried and visualized under a microscope to check spreading of metaphases and mitotic index followed by aging overnight at 60°C for staining with Giemsa and GTG banding (Giemsa banding). Metaphases were karyotyped using the CytoVision software, Leica Biosystems, Bengaluru, Karnataka, India and analyzed for numerical or structural chromosomal abnormalities under 100× oil immersion objective. A minimum of 20–30 banded metaphases were captured using image analysis through a charged-coupled device camera.
1 × 104 cells suspended in the growth media (DMEM low glucose, prostate-specific antigen [PSA], 500 μl Gluta XL and 10% fetal bovine serum [FBS]) were seeded onto a coverslip placed in 12-well plates to carry out immunofluorescence staining with a specific panel of markers. On attaining 40%–50% confluency, growth media (DMEM low glucose, PSA, 500 μl Gluta XL and 10% FBS) were aspirated using serological pipettes and discarded in sterile test tubes. The cells on the coverslip were washed thrice in 1× phosphate-buffered saline (PBS) at room temperature. Fixation was carried out using methanol (−20°C) and incubated for 10 min. 0.05% Triton X was used for permeabilization. Postpermeabiliazation blocking was performed using blocking solution (3% goat serum, 1% bovine serum antigen in PBS and 16.3 M glycine) for 60 min. Later, the blocking solution was discarded and the primary antibodies (TGFβR1, s100a4, vimentin and phalloidin in blocking solution) were added.,,, The cells were incubated overnight in a humidified chamber at 4°C. The next day, primary antibodies were aspirated using serological pipets and discarded in sterile test tubes. Secondary antibodies (goat anti-rabbit IgG monoclonal fluorescein isothiocyanate tagged and goat anti-mouse IgG monoclonal tetramethylrhodamine [TRITC] tagged) were added and incubated for 60 min. Counterstaining was performed using 4',6-diamidino-2-phenylindole (DAPI) with an incubation time of 20 min. Mounting was performed using an antifading agent 1,4-diazobicyclo-2, 2, 2-octane medium. The mounted cells on the coverslip were then observed using confocal microscope.
MTS was performed, wherein HBFs were seeded onto 12-well culture plates and allowed to grow to 50% confluency. On attaining the desired confluency, fixation was carried out using methanol at −20°C. Staining was carried out stepwise with freshly prepared MTS according to the protocol earlier published by Adtani et al. (2017).
| Results|| |
On initial microscopic evaluation, live cells at the time of seeding appeared round [Figure 1]a. Microscopy of the cultures on incubation for 72 h showed attached monolayer of spindle-shaped fibroblasts in FBS [Figure 1]b. Fibroblasts showed complete (80%) confluency on day 9 [Figure 1]c.
On genetically characterizing the attached cells, G-banding of chromosomes of cultured buccal fibroblast cells showed normal chromosomal morphologies with no chromosomal abnormalities [Figure 2].
|Figure 2: Karyogram from cultured human buccal fibroblasts using Giemsa staining|
Click here to view
Microscopic analysis of cultured cells showed normal fibroblast growth in cultures. Immunofluorescence staining was performed to ensure and confirm the cell type and origin. The mesenchymal origin of the cultured cells was confirmed by positive staining with vimentin [Figure 3]b and [Figure 3]c. Fibroblastic phenotyping was performed using fibroblastic-specific protein-1 (Fsp1, s100a4), a characteristic fibroblastic filament-associated calcium-binding protein [Figure 3]e and [Figure 3]f. The nucleus of fibroblast cells was counterstained with DAPI [Figure 3]a and [Figure 3]d.
|Figure 3: Immunofluorescence staining of cultured human buccal cells leading to the formation of homogenous fibroblast cells. Vimentin (b and c) staining indicated mesenchymal origin, while s100a4 (e and f) detected the intracellular filaments in fibroblasts. Surface protein receptor (g) transforming growth factor β receptor 1 indicated the fibrotic nature of the differentiated cells, while phalloidin (h) was used to show the presence of actin filaments in such cells. 4',6-diamidino-2-phenylindole staining of nucleated cells confirmed the viability of the growing cells (a and d), (i) Merged image (TGFβR1 and phalloidin)|
Click here to view
Cells stained positive for TGFβR1, a potent fibrotic mediator that indicates its presence on the cell surface of differentiated cells. The cytoplasm of cultured cells exhibited positive phalloidin staining, indicating the contractile property of fibroblasts [Figure 3]g, [Figure 3]h, [Figure 3]i. Thus, using these immunomarkers, we established a protocol to culture normal primary fibroblasts in vitro.
Morphological assessment of human buccal fibroblasts and qualitative assessment of collagen
Masson trichrome is a connective tissue stain, used to differentiate between collagen and smooth muscle in normal and pathological tissue. It helps to qualitatively assess the effects of antifibrotic agents on ECM deposition. MTS [Figure 4] revealed fibroblasts with spindle morphology and faintly stained collagen fibers, thereby demonstrating no fibrotic activity in the ECM.
|Figure 4: Qualitative assessment of collagen deposition and fibroblast morphology in cultured cells (MTS, ×40). Adtani et al. Translational Research in Oral Oncology|
Click here to view
| Discussion|| |
In the present study, primary adherent fibroblast cell culture model using buccal tissue samples from healthy volunteers was established. Confluent fibroblast monolayer obtained on the 3rd day of seeding [Figure 1]a, [Figure 1]b, [Figure 1]c showed normal karyotype [Figure 2].
The immunohistological pattern of fibroblast cell differentiation was established using specific markers such as vimentin, s100a4, TGFβR1 and phalloidin. Spindle-shaped fibroblasts and mesenchymal origin of the cultured cells were confirmed by positive vimentin staining [Figure 3]. Our results were concurrent with studies performed by Goodpaster et al., who reported maximum (100%) staining intensity with vimentin in dermal and lung fibroblasts when compared to monocyte/macrophage, glioma and osteosarcoma cells explaining its specificity for fibroblasts.
Mathew et al. reported mitotic (FI, FII and FIII) population of fibroblasts cultured from tissues of patients with normal oral mucosa; they observed that FI population of cells have a spindled morphology which stained positive for vimentin. Similar fibroblast morphology was also observed and reported by Bayreuther et al. in skin fibroblasts. Studies done by Waal et al. reported that fibroblasts cultured from patients with normal mucosa and no areca nut chewing habit were of the FI (spindle) type when compared to the FIII type (large pleomorphic and epithelioid) in OSMF patients. In the present study, FI type of fibroblast population was observed.
Fsp1 also called as s100a4 (filament-associated calcium-binding protein) is associated with cells of mesenchymal origin or of fibroblastic phenotype. Cultured HBFs demonstrated s100a4 staining, confirming their fibroblastic phenotype [Figure 3]d, [Figure 3]e, [Figure 3]f. Nishitani et al. also demonstrated Fsp1 expression in fibroblasts accumulating in areas with severe renal interstitial fibrosis.
TGFβ, a potent fibrotic mediator and a scar-inducing factor, is known to be upregulated in many fibrotic conditions; its receptors type I and II are present as cell membrane receptors on cells such as fibroblasts. In the present study [Figure 3]g, [Figure 3]h, [Figure 3]i, accumulation of TGFβR1 present on cultured fibroblasts was demonstrated. A similar study by Komuta et al. in 2010 demonstrated TGFβR1 via in situ hybridization (immunofluorescence staining) on meningeal fibroblasts in mouse brain tissue.
The cultured human fibroblasts showed intracellular cytoplasmic staining with phalloidin, a dye specific for actin filaments [Figure 3]g, [Figure 3]h, [Figure 3]i. Verderame et al. also demonstrated thick actin filaments stained with phalloidin, well distributed throughout the cytoplasm in a 3T3 rat fibroblast cell line. Thus, a primary confluent buccal fibroblast culture which demonstrated mesenchymal origin and fibroblast cell-type properties was obtained that can be used for testing natural or synthetic compounds for their antifibrotic activity.
| Conclusion|| |
The present study lays down a protocol to design and characterize primary buccal fibroblast cell culture model that would aid researchers in performing in vitro preliminary experiments in areas concerning fibrosis.
The authors wish to thank Dr. Solomon FD Paul and Dr. Teena Koshy, Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research for their extended help in performing karyotyping.
Financial support and sponsorship
One of the authors received funding under the ICMR - TALENT SEARCH SCHEME from the Indian Council of Medical Research, New Delhi, India.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Chole RH, Gondivkar SM, Gadbail AR, Balsaraf S, Chaudhary S, Dhore SV, et al.
Review of drug treatment of oral submucous fibrosis. Oral Oncol 2012;48:393-8.
Rajendran A, Sivapathasudharam B. Shafer's Textbook of Oral Pathology. 6th
ed. Delhi, India: Mosby Elsevier; 2009. p. 96-100.
Yang YH, Lee HY, Tung S, Shieh TY. Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan. J Oral Pathol Med 2001;30:213-9.
Khan I, Agarwal P, Thangjam GS, Radhesh R, Rao SG, Kondaiah P, et al.
Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosis. Growth Factors 2011;29:119-27.
Adtani PN, Narasimhan M, Punnoose AM, Kambalachenu HR. Antifibrotic effect of Centella asiatica
Linn and asiatic acid on arecoline-induced fi brosis in human buccal fi broblasts. J Investig Clin Dent 2017;8:1-9.
Howe B, Umrigar A, Tsien F. Chromosome preparation from cultured cells. J Vis Exp 2014;28:e50203.
Goodpaster T, Legesse-Miller A, Hameed MR, Aisner SC, Randolph-Habecker J, Coller HA, et al.
An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 2008;56:347-58.
Nishitani Y, Iwano M, Yamaguchi Y, Harada K, Nakatani K, Akai Y, et al.
Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int 2005;68:1078-85.
Komuta Y, Teng X, Yanagisawa H, Sango K, Kawamura K, Kawano H, et al.
Expression of transforming growth factor-beta receptors in meningeal fibroblasts of the injured mouse brain. Cell Mol Neurobiol 2010;30:101-11.
Verderame M, Alcorta D, Egnor M, Smith K, Pollack R. Cytoskeletal F-actin patterns quantitated with fluorescein isothiocyanate-phalloidin in normal and transformed cells. Proc Natl Acad Sci U S A 1980;77:6624-8.
Xu C, Wang W, Xu M, Zhang J. Asiatic acid ameliorates tubulointerstitial fibrosis in mice with ureteral obstruction. Exp Ther Med 2013;6:731-6.
Mathew DG, Skariah KS, Ranganathan K. Proliferative and morphologic characterization of buccal mucosal fibroblasts in areca nut chewers: A cell culture study. Indian J Dent Res 2011;22:879. [Full text]
Bayreuther K, Rodemann HP, Hommel R, Dittmann K, Albiez M, Francz PI, et al.
Human skin fibroblasts in vitro
differentiate along a terminal cell lineage. Proc Natl Acad Sci U S A 1988;85:5112-6.
de Waal J, Olivier A, van Wyk CW, Maritz JS. The fibroblast population in oral submucous fibrosis. J Oral Pathol Med 1997;26:69-74.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]